About Annexon (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more
- USD1.75
- USD1.75
- USD1.64
- USD7.85
- 3.70%
- --
- 966.14k
- 1.63M
- 216M
- 1.29
- -64.30%
Stock News
5 hours ago
Alphabet: Waymo's Importance Is Growing
SeekingAlpha
6 hours ago
May FOMC Meeting: Waiting For More Clarity
SeekingAlpha
6 hours ago
Altice USA, Inc. 2025 Q1 - Results - Earnings Call Presentation
SeekingAlpha
yesterday
The U.S. economy might be able to handle any disruption from Trump’s tariffs more easily than Wall Street expects
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
